PROFESSOR Scott Bell, the chief of Australia's Translational Research Institute (TRI), has been elected as a Fellow of the Australian Academy of Health and Medical Sciences (AAHMS), which aims to drive change and provide mentorship to upcoming health and medical researchers.
The election reflects his valuable contributions as a respiratory physician and research leader, particularly his role in developing a new global blueprint to help care for the more than 100,000 people who suffer with cystic fibrosis globally, including 3500 Australians.
In addition to directing the Adult Cystic Fibrosis Centre from 1998 to 2016, Bell (pictured) has been at the helm of TRI, which has been dedicated to translating scientific discoveries into applications for medical practice, since early 2020.
As well as being an honour, Bell said the AAHMS Fellowship is an opportunity to provide expert advice and advocacy in conversations with the community, industry and government about urgent health needs.
"Fellows come from across the health and medical sciences to ensure we have an elected body with representation from different disciplines and areas of expertise," he shared.
"Ultimately, we have been selected to work together to ensure the most pressing health issues facing society can be addressed for everyone's benefit."
Becoming an AAHMS Fellow will see Bell join the likes of Nobel Laureate Prof. Peter Doherty, burns specialist Professor Fiona Wood, and University of Queensland immunologist Prof. Ian Frazer.
He is also accompanied by several other TRI colleagues, and was one of four Queenslanders to be admitted to the academy in 2024.
The above article was sent to subscribers in Pharmacy Daily's issue from 25 Oct 24
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 25 Oct 24
